{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:37:08Z","timestamp":1774384628573,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s13555-026-01674-5","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:33:36Z","timestamp":1772469216000},"page":"1767-1778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies"],"prefix":"10.1007","volume":"16","author":[{"given":"Shawn G.","family":"Kwatra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Msihid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Makhija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simmi","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan B.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9887-8159","authenticated-orcid":false,"given":"Donia","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"1674_CR1","doi-asserted-by":"crossref","unstructured":"Huang AH, Williams KA, Kwatra SG. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6):1559\u201365.","DOI":"10.1016\/j.jaad.2020.04.183"},{"key":"1674_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1022889","author":"J Deng","year":"2022","unstructured":"Deng J, Parthasarathy V, Marani M, et al. Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.1022889.","journal-title":"Front Med"},{"key":"1674_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1011142","author":"V Parthasarathy","year":"2022","unstructured":"Parthasarathy V, Cravero K, Deng J, et al. Circulating plasma IL-13 and periostin are dysregulated type\u00a02 inflammatory biomarkers in prurigo nodularis: a cluster analysis. Front Med. 2022. https:\/\/doi.org\/10.3389\/fmed.2022.1011142.","journal-title":"Front Med"},{"key":"1674_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14570","author":"MP Pereira","year":"2017","unstructured":"Pereira MP, Steinke S, Zeidler C, et al. European Academy of Dermatology and Venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2017. https:\/\/doi.org\/10.1111\/jdv.14570.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1674_CR5","doi-asserted-by":"crossref","unstructured":"Whang KA, Le TK, Khanna R, et al. Health-related quality of life and economic burden of prurigo nodularis. J Am Acad Dermatol. 2022;86(3):573\u201380.","DOI":"10.1016\/j.jaad.2021.05.036"},{"key":"1674_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.04.044","author":"S Steinke","year":"2018","unstructured":"Steinke S, Zeidler C, Riepe C, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.jaad.2018.04.044.","journal-title":"J Am Acad Dermatol"},{"key":"1674_CR7","unstructured":"FDA approves first treatment for prurigo nodularis [press release]. 2022. https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-prurigo-nodularis. Accessed 25 June 2025."},{"key":"1674_CR8","unstructured":"Prurigo nodularis treatment recommended for EU approval [press release]. 2022. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/dupixent. Accessed 25 June 2025."},{"key":"1674_CR9","doi-asserted-by":"crossref","unstructured":"Harb HA-O, Chatila TA-O. Mechanisms of dupilumab. Clin Exp Allergy. 2020;50(1):5\u201314.","DOI":"10.1111\/cea.13491"},{"key":"1674_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2023.2268291","author":"GA-O Biazus Soares","year":"2023","unstructured":"Biazus Soares GA-O, Yosipovitch G. A critical review of dupilumab for adult patients with prurigo nodularis. Expert Rev Clin Immunol. 2023. https:\/\/doi.org\/10.1080\/1744666x.2023.2268291.","journal-title":"Expert Rev Clin Immunol"},{"key":"1674_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02320-9","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, St\u00e4nder SA-O, et al. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase\u00a03 trials. Nat Med. 2023. https:\/\/doi.org\/10.1038\/s41591-023-02320-9.","journal-title":"Nat Med"},{"key":"1674_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.1634","author":"SG Kwatra","year":"2024","unstructured":"Kwatra SG, Yosipovitch G, Kim B, et al. Worst itch numeric rating scale for prurigo nodularis: a secondary analysis of 2 randomized clinical trials. JAMA Dermatol. 2024. https:\/\/doi.org\/10.1001\/jamadermatol.2024.1634.","journal-title":"JAMA Dermatol"},{"key":"1674_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19800","author":"SA-O Stander","year":"2024","unstructured":"Stander SA-O, Kim BS, Guillemin I, et al. Estimating meaningful change thresholds for skin pain-numeric rating scale, sleep-numeric rating scale and dermatology life quality index in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024. https:\/\/doi.org\/10.1111\/jdv.19800.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1674_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20099","author":"SG Kwatra","year":"2024","unstructured":"Kwatra SG, Yosipovitch G, St\u00e4nder SA-O, et al. Responder analysis using clinically meaningful thresholds: post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024. https:\/\/doi.org\/10.1111\/jdv.20099.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1674_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2024.09.015","author":"C Bachert","year":"2025","unstructured":"Bachert C, Khan AH, Hopkins C, et al. Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab. Ann Allergy Asthma Immunol. 2025. https:\/\/doi.org\/10.1016\/j.anai.2024.09.015.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1674_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.2060","author":"M Najib","year":"2014","unstructured":"Najib M, Westerhout KY, Verheggen B, Schreder CH. Impact of allergen immunotherapy on symptom-free days and health care costs in patients with grass pollen-induced allergic rhinitis in Germany. Value Health. 2014. https:\/\/doi.org\/10.1016\/j.jval.2014.08.2060.","journal-title":"Value Health"},{"key":"1674_CR17","doi-asserted-by":"crossref","unstructured":"Zhao Y, Han S, Shang J, Zhao X, Pu R, Shi L. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. J Asthma. 2015;52(8):846\u201357.","DOI":"10.3109\/02770903.2015.1014101"},{"key":"1674_CR18","doi-asserted-by":"crossref","unstructured":"Bahloul D, Thomsa R, Rhoten S, et al. 42910 Validation of the Sleep Numeric Rating Scale (Sleep-NRS) for measuring sleep quality in adults with Prurigo Nodularis (PN): Results from dupilumab clinical studies. J Am Acad Dermatol. 2023;89(3) Suppl:AB247.","DOI":"10.1016\/j.jaad.2023.07.989"},{"key":"1674_CR19","doi-asserted-by":"crossref","unstructured":"Bahloul D, Thoms RB, Rhoten S, et al. 42899 Validation of the worst-itch numeric rating scale (WI-NRS) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN. J Am Acad Dermatol. 2023;89(3)Suppl:AB103.","DOI":"10.1016\/j.jaad.2023.07.417"},{"key":"1674_CR20","doi-asserted-by":"crossref","unstructured":"Bahloul D, Thoms RB, Rhoten S, et al. 42895 Validation of the skin pain numeric rating scale (NRS) in prurigo nodularis (PN) based on clinical studies of dupilumab in adults with PN. J Am Acad Dermatol. 2023;89(3)Suppl:AB42895.","DOI":"10.1016\/j.jaad.2023.07.416"},{"key":"1674_CR21","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2642","author":"A Reich","year":"2017","unstructured":"Reich A, Chatzigeorkidis E, Zeidler C, et al. Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol. 2017. https:\/\/doi.org\/10.2340\/00015555-2642.","journal-title":"Acta Derm Venereol"},{"key":"1674_CR22","doi-asserted-by":"publisher","unstructured":"Thomas DA-O, McDonald VA-O, Pavord IA-O, Gibson PA-OX. Asthma remission: what is it and how can it be achieved? Eur Respir J. 2022;60(5):2102583. https:\/\/doi.org\/10.1183\/13993003.02583-2021.","DOI":"10.1183\/13993003.02583-2021"},{"key":"1674_CR23","doi-asserted-by":"crossref","unstructured":"Ivan L, Marston HR, Prabhu VG, et al. Successful aging across middle versus high-income countries: an analysis of the role of eHealth literacy associated with loneliness and well-being. Gerontologist\n. 2024;65(1):gnae170.","DOI":"10.1093\/geront\/gnae170"},{"key":"1674_CR24","doi-asserted-by":"publisher","unstructured":"Gro\u00dfsch\u00e4dl F, Marston HR, Ivan L, et al. Age as an important predictor for digital health literacy: cross-sectional evidence of internet users from an international multisite study in North America and EU countries. Educational Gerontol. 2025;1\u201314. https:\/\/doi.org\/10.1080\/03601277.2025.2505568.","DOI":"10.1080\/03601277.2025.2505568"},{"key":"1674_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12222261","author":"S-H Jeong","year":"2024","unstructured":"Jeong S-H, Nam YG. The paradox of digital health: why middle-aged adults outperform young adults in health management utilization via technology. Healthcare. 2024. https:\/\/doi.org\/10.3390\/healthcare12222261.","journal-title":"Healthcare"},{"key":"1674_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11222980","author":"D Garc\u00eda-Garc\u00eda","year":"2023","unstructured":"Garc\u00eda-Garc\u00eda D, Baz\u00e1n MJA, P\u00e9rez-Rivas FJ. Correlation between health and eHealth literacy and a healthy lifestyle: a cross-sectional study of Spanish primary healthcare patients. Healthcare. 2023. https:\/\/doi.org\/10.3390\/healthcare11222980.","journal-title":"Healthcare"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01674-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:05:44Z","timestamp":1774371944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01674-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01674-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shawn G. Kwatra is an advisory board member\/consultant for Abbvie, Celldex Therapeutics, Galderma, Incyte Corporation, Pfizer, Regeneron Pharmaceuticals, and Kiniksa Pharmaceuticals and has served as an investigator for Galderma, Kiniksa Pharmaceuticals, Pfizer Inc., and Sanofi. Sonja St\u00e4nder is an investigator for Dermasence, Galderma, Kiniksa, Menlo, Novartis, Sanofi, Trevi; advisor for Almirall, Beiersdorf, Bellus Health, Bionorica, Cara, DS Biopharma, Galderma, Kiniksa, Menlo, Novartis and Trevi. Brian S. Kim is an investigator for Cara Therapeutics and Leo Pharma; advisor for Abbvie, Almirall, Amagma, Bristol-Myers Squibb, Cara therapeutics, Eli Lilly and company, Guidepoint Global, Incyte corporation, Lecture Linx, Boehringer Ingelheim, Bellus Health, Blueprint medicines, Daewoong Pharmaceuticals, Granular Therapeutics, Maruho, Om Pharma, Janssen Pharmaceuticals, Kiniksa, LEO Pharma, Menlo, Novartis, Pfizer, Recens Medical, Sanofi, Shaperon, Third rock ventures and Trevi therapeutics; Stock ownership in Locus Biosciences and Nuogen Pharma. Donia Bahloul, Melanie Makhija, Simmi Wiggins, and Jerome Msihid are employees of Sanofi and may hold stock\/stock-options in Sanofi. Ryan B. Thomas, Joseph Zahn and Ashish Bansal are employees of, and stockholders in, Regeneron Pharmaceuticals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies [\n                      \n                      ] and does not contain any new studies with human participants or animals performed by any of the authors. The studies included in this article have been approved by the relevant institutional review boards and ethics committees of centres where studies were conducted (refer to Table\u00a0\n                      \n                      in the electronic supplementary material). The institutional review board or independent ethics committee at all centres approved the protocol, investigator\u2019s brochure, and any information provided to patients. The trials were previously conducted according to the ethical principles of the Declaration of Helsinki. Results presented in this article do not consist of any personally identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}